Literature DB >> 24987921

Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.

Ha-Jeong Kim1, Ji-Hee Sung, Eunjung Lee, Soomin Ahn, Sang Yong Song, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee.   

Abstract

OBJECTIVE: The objectives of this study were to analyze the clinicopathologic features of villoglandular adenocarcinoma (VGA) of the uterine cervix, a variant of cervical adenocarcinoma with good prognosis, and to discuss the association of human papillomavirus (HPV) infection with VGA.
METHODS: A retrospective review of medical records was performed to identify the patients with VGA between 1999 and 2007 at the Samsung Medical Center.
RESULTS: Fifteen patients were identified among 171 women diagnosed with adenocarcinoma of the cervix. The median age was 40 years (range, 32-72 years). Four patients were treated by cone biopsy and 10 patients by hysterectomy with or without pelvic lymphadenectomy. Five patients had invasion of more than half of the depth of tumor in the cervix. Lymphovascular space invasion was present in 2 patients, one of whom also had lymph node metastases. Three recurrences were identified during the median follow-up of 64 months (range, 9-149 months). An HPV test was positive in 6 of 7 patients. Of the 6 patients with HPV infection, 2 were positive for HPV type 18, one for HPV type 6, and the remaining 3 were positive for 1 or more types of high-risk HPV.
CONCLUSIONS: Although VGA has been reported to have a favorable prognosis, we observed recurrences in those patients with close margins by the tumor, lymph node metastasis, or advanced stage. Human papillomavirus DNA, mostly HPV types 16 and 18, was associated with VGA. Further studies are warranted on prognostic factors and the pathogenetic role of HPV infections.

Entities:  

Mesh:

Year:  2014        PMID: 24987921     DOI: 10.1097/IGC.0000000000000197

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  A retrospective review of 11 cases of villoglandular papillary adenocarcinoma of the uterine cervix and a review of the literature.

Authors:  Liping Zhao; Tianmin Xu; Manhua Cui; Zeming Fu
Journal:  Oncol Lett       Date:  2016-02-01       Impact factor: 2.967

2.  Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.

Authors:  Peng Guo; Pengfei Liu; Junjun Yang; Tong Ren; Yang Xiang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

Review 3.  Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.

Authors:  Anna K Dietl; Matthias W Beckmann; Konrad Aumann
Journal:  Arch Gynecol Obstet       Date:  2021-05-25       Impact factor: 2.344

Review 4.  A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.

Authors:  Yixuan Zhang; Yuxiang Wang; Yan Liu; Jing Yang; Congrong Liu
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-07-01

5.  Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?

Authors:  U Chul Ju; Woo Dae Kang; Seok Mo Kim
Journal:  J Gynecol Oncol       Date:  2018-03-20       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.